Novavax soars after U.S. government awards firm $1.6 billion for coronavirus vaccine development
July 07, 2020 at 06:12 AM EDT
The U.S. government has awarded Novavax $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021.
